Skip Navigation

   

DIADS-2 Publications

2005

Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS, Rabins PV, Meinert CL, Martin BK, Lyketsos CG and for the Depression in Alzheimer Disease Study-2: Clinical application of operationalized criteria for ‘Depression of Alzheimer’s Disease.’  Int J Geriatr Psychiatry, 20: 119-127, 2005.

2006

Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG: Design of Depression in Alzheimer's Disease Study-2. Am J Geriatr Psychiatry. 14(11):920-930, 2006.

2010

Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG, for the DIADS-2 Research Group. Do treatment effects vary among differing baseline depression criteria in Depression in Alzheimer’s Disease Study – 2 (DIADS-2)? Int J Geriatr Psychiatry (in press).

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, for the DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer’s disease: Week-24 outcomes. Am J Geriatr Psychiatry. 2010 Apr; 18(4):332-340. NIHMSID: NIHMS181111.

Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos, CG, for the DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer’s disease. Am J Geriatr Psychiatry. 2010 Feb; 18(2):136-45. NIHMSID: NIHMS166961.

 

© , Johns Hopkins University. All rights reserved.
Web policies, 615 N. Wolfe Street, Baltimore, MD 21205